Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Disparities in fertility-sparing surgery in adolescent and young women with stage I ovarian dysgerminoma.

Stafman LL, Maizlin II, Dellinger M, Gow KW, Goldfarb M, Nuchtern JG, Langer M, Vasudevan SA, Doski JJ, Goldin AB, Raval M, Beierle EA.

J Surg Res. 2018 Apr;224:38-43. doi: 10.1016/j.jss.2017.11.046. Epub 2017 Dec 22.

2.

Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.

Turkmen O, Karalok A, Basaran D, Kimyon GC, Tasci T, Ureyen I, Tulunay G, Turan T.

J Adolesc Young Adult Oncol. 2017 Jun;6(2):270-276. doi: 10.1089/jayao.2016.0086. Epub 2017 Jan 13.

PMID:
28085535
3.

Is fertility sparing surgery a treatment option for premenopausal patients with dysgerminoma?

Iavazzo C, Vorgias G, Iavazzo PE, Gkegkes ID.

Bratisl Lek Listy. 2016;117(12):738-740. doi: 10.4149/BLL_2016_131.

PMID:
28127973
4.

Fertility-preserving surgery for advanced stage ovarian germ cell tumors.

Nasioudis D, Frey MK, Chapman-Davis E, Caputo TA, Holcomb K.

Gynecol Oncol. 2017 Dec;147(3):493-496. doi: 10.1016/j.ygyno.2017.10.010. Epub 2017 Oct 9.

PMID:
29021083
5.

Treatment of malignant ovarian germ cell tumors with preservation of fertility: a report of 28 cases.

Wu PC, Huang RL, Lang JH, Huang HF, Lian LJ, Tang MY.

Gynecol Oncol. 1991 Jan;40(1):2-6.

PMID:
1846603
6.

Socioeconomic disparities affect survival in malignant ovarian germ cell tumors in AYA population.

Bownes LV, Stafman LL, Maizlin II, Dellinger M, Gow KW, Goldin AB, Goldfarb M, Langer M, Raval MV, Doski JJ, Nuchtern JG, Vasudevan SA, Beierle EA.

J Surg Res. 2018 Feb;222:180-186.e3. doi: 10.1016/j.jss.2017.09.013. Epub 2017 Oct 6.

7.

Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence.

Topuz S, Iyibozkurt AC, Akhan SE, Keskin N, Yavuz E, Salihoglu Y, Bengisu E, Berkman S.

Eur J Gynaecol Oncol. 2008;29(6):635-7.

PMID:
19115694
8.

[Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors].

Liu Q, Ding XL, Yang JX, Cao DY, Shen K, Lang JH, Zhang GN, Xin XY, Xie X, Zhang SL, Wu YM, Zhu GH, Wang J, Chen YL, Kong BH, Zheng JH.

Zhonghua Fu Chan Ke Za Zhi. 2013 Mar;48(3):188-92. Chinese.

PMID:
23849941
9.

Pure dysgerminoma of the ovary: a review of 45 well staged cases.

Ayhan A, Bildirici I, G├╝nalp S, Yuce K.

Eur J Gynaecol Oncol. 2000;21(1):98-101.

PMID:
10726633
10.

Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report.

Ghalleb M, Bouzaiene H, Slim S, Hadiji A, Hechiche M, Ben Hassouna J, Rahal K.

J Med Case Rep. 2017 Dec 17;11(1):350. doi: 10.1186/s13256-017-1516-8.

11.

Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.

Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.

Int J Gynecol Cancer. 2016 Jun;26(5):859-64. doi: 10.1097/IGC.0000000000000702.

PMID:
27101582
12.

Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?

Shah R, Xia C, Krailo M, Amatruda JF, Arul SG, Billmire DF, Brady WE, Covens A, Gershenson DM, Hale JP, Hurteau J, Murray MJ, Nicholson JC, Olson TA, Pashankar F, Rodriguez-Galindo C, Shaikh F, Stark D, Frazier AL, Stoneham S.

Gynecol Oncol. 2018 Aug;150(2):253-260. doi: 10.1016/j.ygyno.2018.05.025. Epub 2018 Jun 5.

PMID:
29884437
13.

Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.

Ertas IE, Taskin S, Goklu R, Bilgin M, Goc G, Yildirim Y, Ortac F.

J Obstet Gynaecol Res. 2014 Mar;40(3):797-805. doi: 10.1111/jog.12253. Epub 2013 Dec 10.

PMID:
24320102
14.

Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.

Ayhan A, Celik H, Taskiran C, Bozdag G, Aksu T.

Eur J Gynaecol Oncol. 2003;24(3-4):223-32. Review.

PMID:
12807228
15.

[A primary malignant mixed germ cell tumor of the ovary].

de Groot AW, Wagenaar SS.

Ned Tijdschr Geneeskd. 1978 Oct 28;122(43):1657-60. Dutch. No abstract available.

PMID:
81470
16.

Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?

Nasioudis D, Chapman-Davis E, Frey MK, Witkin SS, Holcomb K.

J Gynecol Oncol. 2017 Nov;28(6):e71. doi: 10.3802/jgo.2017.28.e71. Epub 2017 Jul 3.

17.

[Results of fertility preserving operations in malignant ovarian tumors].

Kleine W.

Zentralbl Gynakol. 1996;118(6):317-21. Review. German.

PMID:
8768006
18.

Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.

Lerro CC, Robbins AS, Fedewa SA, Ward EM.

Urol Oncol. 2014 Jan;32(1):23.e15-21. doi: 10.1016/j.urolonc.2012.08.012. Epub 2013 Feb 8.

PMID:
23395701
19.

[Treatment of pure stage one ovarian dysgerminoma in young women. Report of a case and review of the literature].

Mazza D, Pozzi M, Sedati A, Vocaturo G.

Minerva Ginecol. 1999 Jan-Feb;51(1-2):27-30. Review. Italian.

PMID:
10230241
20.

Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age.

Jiang X, Yang J, Yu M, Xie W, Cao D, Wu M, Pan L, Huang H, You Y, Shen K.

World J Surg Oncol. 2017 Aug 15;15(1):154. doi: 10.1186/s12957-017-1222-4.

Supplemental Content

Support Center